Lawson MacArtney Net Worth & Insider Trades
Lawson MacArtney - Director, Viking Therapeutics, Inc
What is Lawson MacArtney's Net Worth?
The current estimated net worth of Viking Therapeutics, Inc's Director, Lawson MacArtney, is estimated to be about $1.7M . Lawson MacArtney owns about 47,965 units of Viking Therapeutics, Inc common stock. In the last 8 years at Viking Therapeutics, Inc, Lawson MacArtney has sold an estimated value of $1.15M worth.
What is Lawson MacArtney's Past Insider Trading?
Lawson MacArtney's largest purchase order was 47,965 units , worth over $250.33K on May 31, 2018. Lawson MacArtney's largest sale order was 20,786 units , worth over $415.72K on April 18, 2023. In total, Lawson MacArtney has made about 13 transactions over 8 years of their time at Viking Therapeutics, Inc. Lawson MacArtney usually trades in January, with the busiest year in 2023. The most recent transaction was a sale order of 16,000 units , worth over $384K on May 18, 2023.
LAWSON MACARTNEY
Date Range: All Time
Ticker
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||
What is Lawson MacArtney's' Mailing Address?
- Mailing address is C/o Ambrx, Inc. 10975 N. Torrey Pines Rd. La Jolla CA 92037 CA
Viking Therapeutics, Inc Executive Compensation
Name |
Year
|
Salary
|
Other Earnings Plans or Compensations
|
Stock Awards
|
Option Awards
|
Other Compensation
|
Total
|
|---|---|---|---|---|---|---|---|
| Brian Lian, Ph.D. | 2020 | $577,000 | $301,000 | $2,485,102 | $1,824,346 | - | $5,187,448 |
| Brian Lian, Ph.D. | 2019 | $525,000 | $210,000 | $1,530,379 | $1,246,740 | - | $3,512,119 |
| No matching records found | |||||||
Source: https://www.sec.gov/Archives/edgar/data/1607678/000156459021018175/vktx-def14a_20210520.htm
What are Viking Therapeutics, Inc's Past Insider Trades?
Viking Therapeutics, Inc's most recent insider trade came on May 18, 2023 by Charles Rowland Jr who sold 40,000 units worth $1M . In the last 8 years, insiders at Viking Therapeutics, Inc have sold an estimated value of $37.43M and bought an estimated value of $6.67M worth of shares. Insider trading is most common in January, with the busiest year in 2023. The most active traders at the company are Brian Lian, President & CEO, Michael Morneau, VP, and Matthew Foehr, Director .
Viking Therapeutics, Inc. Insider Trades
Date Range: All Time
Insider Names
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||